Harbin Liqiang Pharmaceutical

Harbin Liqiang Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the Harbin Pharmaceutical Group (Hayao). The company specializes in the production of traditional Chinese medicine (TCM) injections, generic small molecule drugs, and health supplements. Its core product line includes cardiovascular treatments like Compound Salvia Miltiorrhiza Injection and respiratory therapies such as Shuanghuanglian and Qingkailing Injections. Harbin Liqiang operates extensive manufacturing facilities in Harbin, Heilongjiang, focusing on high-volume production for the domestic healthcare market. The company plays a significant role in the supply chain of essential medicines within China's public health system.